HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.

AbstractAIMS:
To evaluate the suitability of malignant pleural effusion (MPE) and plasma as surrogate samples for epidermal growth factor receptor (EGFR) mutation detection, and compare three different detection methods.
METHODS:
Matched tissue and plasma samples were collected from patients with advanced non-small cell lung cancer (NSCLC) (stage IIIB/IV adenocarcinoma/adenosquamous carcinoma), with matched MPE samples collected from a subgroup. DNA was extracted from tissue, MPE cell block, MPE supernatant and plasma before mutation detection by amplification refractory mutation system (ARMS) (all samples), Sanger sequencing and mutant-specific immunohistochemistry (IHC) (tissue and MPE cell blocks only).
RESULTS:
Sensitivity of MPE cell block, MPE supernatant and plasma versus tissue: 81.8% (9/11), 63.6% (7/11) and 67.5% (27/40); specificity was 80.0% (8/10), 100% (10/10) and 100% (46/46), respectively. Sensitivity of Sanger sequencing versus ARMS: 81.8% (27/33) for tissue, 40% (4/10) for MPE cell blocks; specificity was 100% (36/36 and 12/12) for both. Sensitivity of mutant-specific IHC versus ARMS: 54.8% (17/31) for tissue, 50.0% (6/12) for MPE cell blocks; specificity was 97.1% (34/35) and 100% (14/14), respectively.
CONCLUSIONS:
MPE and plasma are valid surrogates for NSCLC tumour EGFR mutation detection when tissue is not available. ARMS is most suitable for mutation detection in tissue and MPE cell blocks; however, mutant-specific IHC could be a complementary method when DNA-based molecular testing is unavailable.
AuthorsXiaoqing Liu, Yachao Lu, Guanshan Zhu, Yao Lei, Li Zheng, Haifeng Qin, Chuanhao Tang, Gillian Ellison, Rose McCormack, Qunsheng Ji
JournalJournal of clinical pathology (J Clin Pathol) Vol. 66 Issue 12 Pg. 1065-9 (Dec 2013) ISSN: 1472-4146 [Electronic] England
PMID23888061 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
  • ErbB Receptors
Topics
  • Adenocarcinoma (genetics, metabolism, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Adenosquamous (genetics, metabolism, pathology)
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism, pathology)
  • China
  • DNA, Neoplasm (chemistry, genetics)
  • ErbB Receptors (genetics, metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Male
  • Middle Aged
  • Mutation
  • Plasma
  • Pleural Effusion, Malignant (genetics, metabolism, pathology)
  • Sensitivity and Specificity
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: